Hengrui Medicine Sets Up Wholly-Owned Shanghai Subsidiary with RMB 50 Million Capital

Hengrui Medicine has recently established a new subsidiary in Shanghai. The company, named Hengrui Yuanke (Shanghai) Pharmaceutical Co. , Ltd. , has Lu Yun as its legal representative and registered capital of RMB 50 million. Its business scope covers drug production, entrusted drug manufacturing, drug retail and pharmaceutical import and export. The subsidiary is wholly owned by Hengrui Medicine.